A Case of Miller Fisher Syndrome and Literature Review

Случай синдрома Миллера—Фишера и обзор литературы
Sumera Bukhari, Javier Taboada
2017-02-22

Guillain-Barré syndromeMiller Fisher syndromealbuminocytologic dissociationintravenous immune globulinophthalmoplegia
Miller Fisher syndrome (MFS) was first recognized by James Collier in 1932 as a clinical triad of ataxia, areflexia, and ophthalmoplegia. Later, it was described in 1956 by Charles Miller Fisher as a possible variant of Guillain-Barré syndrome (GBS). Here, we write a case of a patient with atypical presentation of this clinical triad as the patient presented with double vision initially due to unilateral ocular involvement that progressed to bilateral ophthalmoplegia. He developed weakness of the lower extremities and areflexia subsequently. A diagnosis of MFS was made due to the clinical presentation and the presence of albuminocytologic dissociation in the cerebrospinal fluid (CSF) along with normal results of brain imaging and blood workup. The patient received intravenous immune globulin (IVIG), and his symptoms improved. The initial diagnosis of MFS is based on the clinical presentation and is confirmed by cerebral spinal fluid analysis and clinical neurophysiology studies. This case which emphasizes the knowledge of a rare syndrome can help narrow down the differentials to act promptly and appropriately manage such patients.
1
Diagnosis is primarily clinical and can be supported by cerebrospinal-fluid analysis and clinical neurophysiology studies.
2
Miller Fisher syndrome was diagnosed from the characteristic clinical progression together with cerebrospinal-fluid albuminocytologic dissociation and normal brain imaging and blood tests.
3
The case highlights that early recognition of this rare Guillain–Barré syndrome variant can narrow differential diagnoses and support prompt management.
4
The reported patient initially had unilateral ocular involvement causing diplopia, which progressed to bilateral ophthalmoplegia before lower-extremity weakness and areflexia developed.
5
Treatment with intravenous immune globulin was followed by clinical improvement.

A patient with Miller Fisher syndrome (MFS) presenting with initially unilateral and subsequently bilateral ophthalmoplegia, lower-extremity weakness, and areflexia

The atypical clinical presentation, diagnostic confirmation, and response to intravenous immune globulin treatment of Miller Fisher syndrome

Publication Details
Publication Date
2017-02-22
Journal
Publisher
ISSN
Cited by
55
Access Type
Author Information
Authors
Sumera Bukhari
Javier Taboada
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%